Skaff Michael C
10% owner
PurchaseAlert
- Shares
- 2,749,330
- Price
- $0.58
- Value
- $1,600,110
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•12 filings
VVOS
Vivos Therapeutics, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$10,370,220
2 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
8
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get VVOS insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
VVOS overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
17
Raw transactions
Everything returned by the filing
8
Voluntary view
P/S trades after deterministic checks
7
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 12,000
- Price
- $0.00
- Footnotes
- 1
On September 14, 2026 (the "Grant Date"), the Reporting Person received a grant of 12,000 stock options from the Issuer. One-half vested immediately (and the earliest possible exercise date in Table II relates to this tranche), one-fourth will vest on September 30, 2026 and one-fourth will vest on December 31, 2026. The options are exercisable for a period of 10 years from the Grant Date. Reflects expiry of 667 options on June 19, 2025 and 1,200 options on August 5, 2026, all of which expired unexercised.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Skaff Michael C
10% owner
PurchaseAlert
- Shares
- 1,890,164
- Price
- $0.58
- Value
- $1,100,075
Skaff Michael C
10% owner
PurchaseAlert
- Shares
- 859,166
- Price
- $0.58
- Value
- $500,035
Skaff Michael C
10% owner
PurchaseAlert
- Shares
- 308,848
- Price
- $1.34
- Value
- $413,856
Skaff Michael C
10% owner
PurchaseAlert
- Shares
- 1,044,777
- Price
- $1.34
- Value
- $1,400,001
Skaff Michael C
10% owner
PurchaseAlert
- Shares
- 1,783,582
- Price
- $1.34
- Value
- $2,390,000
Skaff Michael C
10% owner
PurchaseAlert
- Shares
- 1,783,582
- Price
- $1.34
- Value
- $2,390,000
Skaff Michael C
10% owner
PurchaseAlert
- Shares
- 429,957
- Price
- $1.34
- Value
- $576,142
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Skaff Michael C 10% owner | Purchase | 2,749,330 | $0.58 | $1,600,110 | |
| Jun 30, 2026 | Skaff Michael C 10% owner | Purchase | 1,890,164 | $0.58 | $1,100,075 | |
| Jun 30, 2026 | Skaff Michael C 10% owner | Purchase | 859,166 | $0.58 | $500,035 | |
| Mar 31, 2026 | Skaff Michael C 10% owner | Purchase | 308,848 | $1.34 | $413,856 | |
| Mar 31, 2026 | Skaff Michael C 10% owner | Purchase | 1,044,777 | $1.34 | $1,400,001 | |
| Mar 31, 2026 | Skaff Michael C 10% owner | Purchase | 1,783,582 | $1.34 | $2,390,000 | |
| Mar 31, 2026 | Skaff Michael C 10% owner | Purchase | 1,783,582 | $1.34 | $2,390,000 | |
| Mar 31, 2026 | Skaff Michael C 10% owner | Purchase | 429,957 | $1.34 | $576,142 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.